90%, but the four year survival rate of cases registered as 'early gastric cancer' but said by the panel to have more advanced disease was under 75%. These findings may account for some of the differences between series, and emphasise the need for precise, widely agreed criteria for the diagnosis of early gastric cancer and gastric dysplasia.
The frequency with which gastric cancer occurs (accounting for over 10% of cancer deaths per year in the United Kingdom), and the poor survival rate despite modern forms of surgery (under 10% at five year overall) are well recognised.' These depressing statistics are doubly disquieting because exhaustive studies have shown beyond reasonable doubt that the prognosis of gastric cancer is related to its clinicopathological staging. 2 In the last decades, an increasing number of reports concerning 'early gastric cancer' have been stimulated by original work carried out in Japan. 7 At least two studies from the United Kingdom have attempted to delineate the features of cancers where invasion by the primary tumour is restricted to the mucosa and submucosa of the stomach by the time the cancer is resected. 89 Evans and colleagues8 reported 14 such cases with clinical and histopathological characteristics similar to those found in Japanese patients. Fielding and colleagues'9 have, however, shown that in current practice, the number of 'early gastric cancers' remains depressingly small. In the Birmingham series out of over 13 000 patients with gastric cancer, only 90 fully filled the above criteria for early disease.
Both these previous excellent surveys suggested that earlier and more effective investigation of patients with dyspepsia might increase the detection rate for early gastric cancer; but over the years there has been lively debate about the mode of presentation of early gastric cancer in the United Kingdom, and also about means of classifying such cases.
At Once it was decided to enter a patient, the relevant 'dossier' of information concerning basic, symptomatic, endoscopic and histopathological data was sent to the coordinating centre in Leeds, using a predefined and common proforma. Methods of (computer based) analysis have been described elsewhere."'0'
Pathological material In addition on entry to the study, relevant slides were forwarded to the co-ordinating centre and thence onwards for additional examination by survey histopathologists.
The flow diagram in Figure 1 I2 Dysplasia was defined as histological abnormalities of cytology and/or architecture which were considered to be neoplastic but which did not amount to unequivocal carcinoma, divided into high grade and low grade dysplasia depending upon the severity of the abnormalities."
Follow up Once the case was entered into the trial follow up was obtained on a yearly basis, via a predefined and pre-agreed proforma. This took place for all cases, whether defined as being early gastric cancer or not, until five years had elapsed after the initial diagnosis and entry into the trial. Table I shows the patients, according to final panel diagnosis, provided from the referring centres. In all, a total of 77 consultants in 41 hospitals referred some 319 cases.
Patients
Of the 319 cases entered into the survey, a total of 132 patients (41-4%) were finally classified as having early gastric cancer. A further 63 patients (19-7%) were classified as having dysplasia, and no less than 55 patients (17-2%) were ultimately an apparently benign gastric ulcer) and in around 10% of cases it was not possible from the case records to assign a patient to one of the above categories.
RADIOLOGICAL AND ENDOSCOPY APPEARANCES
Tables V and VI illustrate the radiological and endoscopic findings and opinions reported, from 33 cases undergoing upper GI radiology and 114 cases undergoing endoscopy. Although the radiological data are scanty, they are disquieting. In only 21% of cases (seven of 33) was a typical cancer seen and though cancer was mentioned in about one third of patients, in 14 patients (42 5%) the appearances were thought to be benign by the radiologist and in seven patients (21-2%) the stomach was said to be completely normal.
The visual findings on endoscopy and the endoscopist's predictions from 114 cases of early gastric cancer are shown in Table VI . Once again the proportion of patients in whom a firm diagnosis of malignancy was made is somewhat low (24 cases, 21-1%). In a further 19 3% of cases malignancy was questioned, but 46 patients' visual endoscopic features were described as 'benign'. SYMPTOMATIC 
ANALYSIS
As almost none of the early gastric cancer cases were diagnosed firmly on symptomatic grounds it became relevant to enquire as to whether there were any 'clues' which could be utilised to improve early diagnosis. Accordingly the symptomatic data from the cases concerned were analysed using a desk top computer as described previously by Clamp Care Study -that is, patients with non-ulcer dyspepsia all followed for at least three years after negative investigations without organic disease being established -were analysed as previously described by comparison with a reference series of just under 1000 cases'01'1 (Table  VII) .
Of the early gastric cancer cases just under 77% were diagnosed as cancer by the computer predictive system, but an almost equal number of 'dysplasia' cases were also diagnosed as cancer by the system. Nevertheless, both early gastric cancer and dysplasia (each of which warrant further urgent investigation) were separated reasonably well from patients with non-organic dyspepsia. The computer placed over 91% of each group (early gastric cancer and dysplasia) in a high risk category as regards cancer, and only two patients with early gastric cancer out of 104 were placed in the 'low risk' category.
PROGRESSION OF SYMPTOMS
Since computer aided prediction can to some extent separate patients at high risk of early gastric cancer, it becomes relevant to ask why this is not currently done. Part of the answer is illustrated in Table VIII . This further analysis compares the symptoms of the 'classical cancer syndrome' in groups of patients with increasingly progressive disease -63 cases of dysplasia from the present series, 132 cases of early gastric cancer, 55 cases registered into the series with early gastric cancer but found to have slightly more extensive disease (tumour just involving the innermost fibres of circular muscle) and finally 100 cases of advanced gastric cancer from earlier Leeds studies.'°T he data indicate that although the classical cancer syndrome is present in almost all of the patients who present routinely in the conventional manner to hospital with advanced gastric cancer, these features are present in only half of the cases with early gastric cancer, and in far less than half of the cases with dysplasia.
FOLLOW UP
Of necessity the data concerning follow up are less complete than those concerning the initial presentation. Some preliminary actuarial data, however, are shown in Figure 2 .
Several aspects are worth comment. First, the five year survival rate (around 90%) of the 132 early gastric cancer cases (calculated on an actuarial basis using the patient year concept) is not dissimilar from that shown in several Japanese series, and rather higher than the age adjusted survival of TI cases from the Birmingham series. ' When the patients are further subdivided, however, according to the 'panel' consensus diagnosis some important differences are seen. The five year survival rate in cases agreed by the panel to have early gastric cancer is high (around 
Discussion
It is important in assessing the results of this survey to emphasise that the survey makes no claim whatsoever to be a rigorous, comprehensive assessment of the international picturenamely, early gastric cancer in the United King- dom. It needs to be re-emphasised that entry into this survey was at the discretion of individual BSG members and the survey can thus provide no evidence at all concerning incidence figures or even the proportion of patients with cancer who have early gastric cancer.
Nevertheless, the study has three features which commend it. First, the number ofpatients overall (319 in toto, 132 with early gastric cancer) is quite large. Second, the patient details provided concerning symptomatic presentation, mode of detection of cancer and so on -are unusually full. Finally, the series is probably unique in that every patient has had histopathological material examined by at least four pathologists and the decision to classify the 132 patients as early gastric cancer has been made in the light of discussions after these independent examinations.
Particularly relevant in this respect is the finding that in 39 cases the original diagnosis of early gastric cancer was not confirmed by the pathologist panel, but after detailed examination, agreed amongst themselves there was evidence of more extensive disease. This finding may go some way to explain (when taken in conjunction with the data in Figure 2 ), the not inconsiderable difference in survival between various series of early gastric cancer around the world -for if the death rate amongst 'pure' early gastric cancer cases is low, and their numbers small, it takes only a few 'contaminating' cases radically to alter apparent survival data.
The data from Tables IV-VI confirm the dominance of histopathological examination of biopsy specimens in establishing the diagnosis of early gastric cancer. Almost all cases where this diagnosis was established before operation were thus diagnosed. This trend is probably justified, for in the relatively few cases coming to radiological investigation, cancer was only diagnosed or suspected in about one third. Even so, the data from In the immediate future, the data presented here would seem to suggest a variety of further studies. First, there is need to categorise more fully and in greater detail both the histopathological features of 'early gastric cancer' and also the various types of dysplasia. This study is nearing completion and will be presented separately. 12 Next, there is need to increase the pool of patients with 'dysplasia' at least to match the cohort numbers; so that more detailed comparisons can be made between the two, and more detailed study be made between the various types of dysplasia.
Finally, there is need to follow up further this interesting cohort of patients, both those with dysplasia and those with early gastric cancer. As regards 'early gastric cancer' cases, their five year survival has been re-assuringly high particularly where all concerned agreed that the patients had early gastric cancer. Nevertheless, it is important to prolong the survival curve to see whether this excellent prognosis is maintained or whether the related mortality has been merely delayed in these patients for a few years by their relatively early cancer detection. 
